Results
1380
Companies which are more than 50% undervalued based on analyst price target.
1,380 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
APP | US$325.74 | -20.6% | 426.5% | US$110.7b | US$504.69 | PE70.2x | E31.3% | n/a | Software | ||
MSTR | US$255.43 | -9.7% | 91.5% | US$66.5b | US$513.01 | PS143.5x | E57.1% | n/a | Software | ||
COIN | US$215.62 | -5.0% | -5.9% | US$54.7b | US$329.54 | PE21.2x | E-8.6% | n/a | Diversified Financials | ||
TTD | US$70.32 | -5.2% | -15.7% | US$34.9b | US$112.06 | PE88.7x | E22.3% | n/a | Media | ||
DECK | US$139.36 | -0.5% | -9.8% | US$21.2b | US$218.89 | PE22.4x | E6.9% | n/a | Consumer Durables | ||
WDC | US$48.93 | -0.2% | -23.9% | US$17.0b | US$78.67 | PE14.1x | E-0.8% | 0% | Tech | ||
SMMT | US$20.69 | 9.8% | 361.8% | US$15.3b | US$34.48 | PB39.3x | E47.7% | n/a | Pharmaceuticals & Biotech | ||
FSLR | US$136.18 | -10.9% | -13.1% | US$14.6b | US$248.02 | PE11.3x | E21.3% | n/a | Semiconductors | ||
ILMN | US$88.74 | -5.6% | -35.6% | US$14.1b | US$142.32 | PS3.2x | E52.3% | 3.5% | Pharmaceuticals & Biotech | ||
ALAB | US$74.35 | -12.1% | n/a | US$12.1b | US$125.03 | PS30.4x | E61.1% | n/a | Semiconductors | ||
MRNA | US$30.96 | -8.7% | -67.8% | US$11.9b | US$56.01 | PS3.7x | E29.5% | n/a | Pharmaceuticals & Biotech | ||
COHR | US$75.19 | -6.3% | 12.4% | US$11.7b | US$115.63 | PS2.2x | E87.0% | n/a | Tech | ||
SRPT | US$106.75 | 1.1% | -13.8% | US$10.3b | US$179.91 | PE44x | E24.3% | n/a | Pharmaceuticals & Biotech | ||
PCVX | US$73.02 | -10.6% | 2.1% | US$9.4b | US$150.22 | PB2.8x | E31.9% | n/a | Pharmaceuticals & Biotech | ||
VFS | US$3.62 | -3.5% | -31.4% | US$8.5b | US$6.33 | PS5.8x | E1.0% | n/a | Automobiles | ||
NBIS | US$32.49 | -10.3% | n/a | US$7.7b | US$55.00 | PS65.2x | S77.4% | n/a | Software | ||
RVMD | US$40.74 | -1.2% | 38.1% | US$7.6b | US$72.50 | PB3.3x | E17.6% | n/a | Pharmaceuticals & Biotech | ||
CACI | US$334.85 | 2.3% | -11.6% | US$7.5b | US$517.62 | PE15.6x | E8.1% | n/a | Commercial Services | ||
ONTO | US$145.66 | -7.8% | -25.2% | US$7.2b | US$247.02 | PE35.6x | E26.2% | n/a | Semiconductors | ||
CZR | US$33.22 | -5.2% | -20.1% | US$7.0b | US$50.06 | PS0.6x | E46.8% | n/a | Consumer Services | ||
BBIO | US$34.90 | -3.7% | 7.9% | US$6.6b | US$52.63 | PS29.9x | E52.0% | n/a | Pharmaceuticals & Biotech | ||
LEGN | US$35.01 | -5.3% | -45.7% | US$6.4b | US$79.26 | PS12.3x | E56.8% | n/a | Pharmaceuticals & Biotech | ||
CORT | US$60.58 | -2.0% | 150.8% | US$6.4b | US$99.75 | PE45.7x | E36.7% | n/a | Pharmaceuticals & Biotech | ||
PSN | US$58.22 | -0.9% | -29.7% | US$6.2b | US$91.12 | PE26.4x | E17.5% | n/a | Commercial Services |